INOZYME PHARMA, INC. Deferred Costs
INOZYME PHARMA, INC. had Deferred Costs of $0 as of 2020-12-31, per its 10-K filed 2021-03-25.
Discontinued › Balance Sheet › Assets
us-gaap:DeferredCostsCurrentAndNoncurrent · last filed 2021-03-25
- 2020-12-31: Deferred Costs $0.00.
- 2020-09-30: Deferred Costs $0.00.
- 2020-06-30: Deferred Costs $2.70M.
- 2019-12-31: Deferred Costs $100.00K.
| Period end | Deferred Costs |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-25 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.70M 10-Q · filed 2020-09-03 |
| 2019-12-31 | $100.00K 10-K · filed 2021-03-25 |